Acurian and Synexus Launch SynexusPlus Enrollment-enhanced Site Solution

Acurian Inc. and Synexus have launched SynexusPlus, an integrated site solution for enrolling patients in clinical studies.

27 Jun. 2018

PPD’s PatientAdvantage Inverts Traditional Clinical Trial Delivery Method

PPD has introduced PatientAdvantage, a new patient enrollment model that significantly reduces the time and cost of conducting clinical trials for pharmaceutical and biotechnology customers.

25 Jun. 2018

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

PPD and NeoGenomics Laboratories, Inc. are forming a strategic alliance to provide a seamless and fully integrated global pathology and molecular testing solution to PPD’s pharmaceutical and biotech clients.

01 Jun. 2018

PPD’s Clinical Research Excellence Celebrated by PharmaTimes

PPD announced that its clinical research expertise was recognized for excellence at the PharmaTimes International Clinical Researcher of the Year competition.

30 May 2018

Forbes Recognizes PPD as One of America’s Best Large Employers

PPD announced it has been named to Forbes magazine’s 2018 list of America’s Best Large Employers.

23 May 2018

PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner

PPD and Evidera have joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS) initiative as a strategic partner.

22 May 2018

PPD Clinical Research Associates Recognized for Excellence

PPD clinical research associates earned recognition for excellence at the annual PharmaTimes Clinical Researcher of the Year–The Americas competition.

10 May 2018

PPD Recognized for Excellence in Clinical Research in CRO Leadership Awards

PPD has been recognized for excellence in clinical research by pharmaceutical and biotechnology executives surveyed for Life Science Leader magazine’s 2018 CRO Leadership Awards.

09 May 2018

Christopher Scully Joins PPD as Chief Financial Officer

PPD announced the appointment of Christopher Scully as executive vice president and chief financial officer.

04 May 2018

Acurian and Synexus Launch NASH Patient Enrollment Solution

Acurian Inc., a leading full-service provider of global patient enrollment and retention solutions, and Synexus, the leading global network of dedicated research sites, have launched a comprehensive solution for enrolling patients in clinical studies for nonalcoholic fatty liver disease (NAFLD) and its advanced form, nonalcoholic steatohepatitis (NASH).

23 Apr. 2018

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.